Implementation of CYP2C19 genotyping to guide proton pump inhibitor use at an academic health center.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists(2023)

引用 2|浏览6
暂无评分
摘要
Guiding PPI prescribing based on CYP2C19 genotype is a practical approach to potentially improve the benefit-risk ratio with PPI therapy. Physician engagement is key for successful implementation. A CPIC guideline on CYP2C19 genotype-guided PPI dosing is now available, and automated alerts may be instituted to facilitate implementation.
更多
查看译文
关键词
proton pump inhibitor use,proton pump inhibitor
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要